J. Hantson

Glycosaminoglycan analogs as a novel anti-inflammatory strategy

M. Teixeira, J. Shaw, M. Schwarz, 2012, Front. Immun..

O-GlcNAcase Inhibitor ASN90 is a Multimodal Drug Candidate for Tau and α-Synuclein Proteinopathies

B. Permanne, C. Wiessner, Solenne Ousson, 2022, ACS chemical neuroscience.

Assessment of microvascular perfusion changes in a rat breast tumor model using SonoVue to monitor the effects of different anti-angiogenic therapies.

A. Broillet, M. Schneider, C. Ruegg, 2005, Academic radiology.

Pharmacophore‐Based Design of Novel Oxadiazoles as Selective Sphingosine‐1‐phosphate (S1P) Receptor Agonists with in vivo Efficacy

Wolfgang H. B. Sauer, U. Boschert, K. Georgi, 2015, ChemMedChem.

PHASE 1 STUDY IN HEALTHY VOLUNTEERS OF THE O-GLCNACASE INHIBITOR ASN120290 AS A NOVEL THERAPY FOR PROGRESSIVE SUPRANUCLEAR PALSY AND RELATED TAUOPATHIES

B. Permanne, C. Wiessner, Manfred Schneider, 2018, Alzheimer's & Dementia.